Hematological Cancers

HEMATOLOGICAL CANCERS

DuoBody®-CD3xCD20 may have therapeutic potential in a variety of B-cell malignancies and B-cell mediated autoimmune diseases.

Bispecific antibody, CD3, CD20, lymphoma, T-cell retargeting, DuoBody